CJC-1295

Also known as: CJC-1295 DAC, Mod GRF 1-29

Status

No approved product. No approved product. A clinical development program existed (with and without DAC — drug affinity complex) and was discontinued.

What it is

A GHRH analogue designed for a longer half-life than the natural hormone — the 'with DAC' version lasts about a week, the 'without' version hours. Both are research chemicals now.

Source

Discontinued development program; no approved product

Sources

No linked primary source is on file for this entry yet.

Educational use only, never medical advice. No doses.